Crowdfunded product Muse Ring One claims to be able to monitor blood pressure The Muse team says it's analyzed over 4,000 ...

Apple and Masimo’s legal battle over the Apple Watch’s Blood Oxygen sensing feature continues this week as both firms meet in ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in ...

The Global Patient Monitoring Devices Market will grow at a compound annual growth rate (CAGR) of 9.8% during the forecast period from 2022-2030. Request To Download Sample of This Strategic Report @ ...

The intense legal feud between Apple and medical technology company Masimo has reached a pivotal moment with Apple winning a nominal victory in the latest round of court battles. A federal jury ...

We want them to stop copying our design” and features,” Apple attorney said, lambasting Masimo for focusing on its innovations in pulse oximetry, the blood-oxygen measurement feature.

which started with the Masimo’s claim that its patents had been infringed by the Apple Watch’s pulse-oximetry feature, which allows Watch owners to measure their blood oxygen levels.

REUTERS/Manuel Orbegozo/File Photo By Blake Brittain Apple convinced a federal jury on Friday that health monitoring ... for reading blood oxygen levels infringed Masimo's patents.

by removing blood oxygen measurement from its flagship smartwatches sold new — a feature that’s still MIA on new devices to this day. On Friday, Apple got a small piece of revenge over Masimo ...

A Delaware jury has determined Masimo’s early smartwatches violated Apple’s design patents, adding momentum to their ongoing IP battle. A Delaware federal jury has ruled that early versions of ...